B. Lank
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Allan Ronald (12 shared papers)G. K. M. Harding (8 shared papers)Marc Gurwith (8 shared papers)James Brunton (3 shared papers)C. F. T. Snelling (1 shared paper)Jutta K. Preiksaitis (1 shared paper)Larry W. Brox (1 shared paper)G. A. LePage (1 shared paper)
- Journals
- The American Journal of Medicine (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)Cancer (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
B. Lank
12 papers receiving 315 citations
Peers
Comparison fields: 5 of 62
- Molecular Medicine 89
- Clinical Biochemistry 88
- Oncology 230
- Applied Microbiology and Biotechnology 16
- Emergency Medicine 51
Countries citing papers authored by B. Lank
This map shows the geographic impact of B. Lank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lank more than expected).
Fields of papers citing papers by B. Lank
This network shows the impact of papers produced by B. Lank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lank. The network helps show where B. Lank may publish in the future.
Co-authors
The 19 scholars most cited alongside B. Lank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 187 | |
| 2 | 1978 | 73 | |
| 3 | 1976 | 42 | |
| 4 | 1978 | 30 | |
| 5 | 1981 | 26 | |
| 6 | 1983 | 21 | |
| 7 | Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections. | 1979 | 11 |
| 8 | 1976 | 10 | |
| 9 | 1978 | 8 | |
| 10 | Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy. | 1982 | 4 |
| 11 | A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys. | 1975 | 4 |
| 12 | 1978 | 2 | |
| 13 | Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms. | 1977 | 1 |
About B. Lank
B. Lank is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Oncology and Epidemiology, having authored 13 papers that have together received 419 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Neutropenia and Cancer Infections (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Essential Oils and Antimicrobial Activity (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Molecular Medicine (89 citations), Clinical Biochemistry (88 citations), Oncology (230 citations), Applied Microbiology and Biotechnology (16 citations) and Emergency Medicine (51 citations). B. Lank has collaborated with scholars based in Canada and United States. Frequent co-authors include Allan Ronald, G. K. M. Harding, Marc Gurwith, James Brunton, C. F. T. Snelling, Jutta K. Preiksaitis, Larry W. Brox, G. A. LePage, D L Tyrrell and Phillip Ng. Their work appears in journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Cancer and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.